FRD delivers robust first-quarter fiscal 2026 results with rising sales, stronger margins and a sharp swing to profitability in key segments.

Elite Pharmaceuticals reports strong first-quarter fiscal 2026 results with rising direct sales, higher-margin products and expanding gross profit.

Elite Pharmaceuticals reports strong first-quarter fiscal 2026 results with rising direct sales, higher-margin products and expanding gross profit.

AIRT reports higher first-quarter fiscal 2026 revenue, driven by strong Ground Support Equipment gains despite a deeper loss.

SIF returns to profitability in third-quarter fiscal 2025 as strong aerospace demand and cost cuts lifted margins and earnings.

SIF returns to profitability in third-quarter fiscal 2025 as strong aerospace demand and cost cuts lifted margins and earnings.

SENEA reports higher first-quarter fiscal 2026 earnings, driven by improved pricing and mix, despite lower sales and co-pack volume issues.

SENEA reports higher first-quarter fiscal 2026 earnings, driven by improved pricing and mix, despite lower sales and co-pack volume issues.

BKTI posts strong second-quarter 2025 results with higher margins, rising federal demand and raised full-year earnings guidance.

CRWS rises on Baby Boom sales, Disney deal expansion and signs of retail recovery despite deeper first-quarter fiscal 2026 losses.